Current standards for modern therapeutic trials in NASH include histopathologic ... the components of grade (steatosis, ballooning, lobular inflammation), loss of zone 3 accentuation, and a ...

Correction of insulin resistance may not be sufficient for treating NASH successfully in the majority of patients, indicating that NASH is the end result of varying pathogenic mechanisms variably ...